Articles related to ANTIVIRALS

In a recent phase 2–3 trial, nirmatrelvir–ritonavir did not significantly shorten the time to COVID-19 symptom resolution compared to placebo, yet it demonstrated a trend towards reduced hospitalization and death rates, emphasizing the importance of tailored treatment strategies.

In the battle against recurrent herpes simplex virus infections, chronic suppressive therapy emerges as a pivotal strategy, diminishing both the physical burden of outbreaks and the psychological weight of potential transmission.

In the high-risk patient cohort, the combination of baricitinib and remdesivir not only demonstrated a significant reduction in mortality and progression to invasive mechanical ventilation but also showcased an enhanced recovery trajectory.

This case report illustrates the diagnostic challenges and effective management of an unusual presentation of nasal herpes simplex virus infection, highlighting the importance of a thorough evaluation and the broad differential diagnosis in patients presenting with necrotic nasal lesions.

The potential of the antiviral combo in reducing the risk of thromboembolic events among post-COVID-19 patients is real. Could it pave the way for more targeted therapeutic strategies in managing post-COVID-19 conditions?